Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 318, pseudogene (RN7SL318P)

Target: RN7SL318P
Molecular classification: Other (Pseudogene)

Overview

RNA, 7SL, cytoplasmic 318, pseudogene (RN7SL318P) is a human pseudogene derived from the 7SL RNA gene, which is not believed to be functional. The 7SL RNA is a component of the signal recognition particle (SRP) complex involved in targeting newly synthesized proteins to the endoplasmic reticulum. However, 7SL pseudogenes like RN7SL318P are non-coding, often truncated or otherwise altered sequences that result from the integration of reverse-transcribed 7SL RNA back into the genome[1][3][4][6][7]. These pseudogenes do not produce functional RNAs or proteins and have no established biological or disease roles, nor are they known to interact with drugs or serve as therapeutic targets.

Other names: RN7SL318P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 318, pseudogene (RN7SL318P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 318, pseudogene (RN7SL318P).

Explore the full profile